<code id='89D9651692'></code><style id='89D9651692'></style>
    • <acronym id='89D9651692'></acronym>
      <center id='89D9651692'><center id='89D9651692'><tfoot id='89D9651692'></tfoot></center><abbr id='89D9651692'><dir id='89D9651692'><tfoot id='89D9651692'></tfoot><noframes id='89D9651692'>

    • <optgroup id='89D9651692'><strike id='89D9651692'><sup id='89D9651692'></sup></strike><code id='89D9651692'></code></optgroup>
        1. <b id='89D9651692'><label id='89D9651692'><select id='89D9651692'><dt id='89D9651692'><span id='89D9651692'></span></dt></select></label></b><u id='89D9651692'></u>
          <i id='89D9651692'><strike id='89D9651692'><tt id='89D9651692'><pre id='89D9651692'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:1
          George Yancopoulos on the 2024 Breakthrough Summit East stage.
          George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

          George Yancopoulos is in touch with his teenage self.

          After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

          advertisement

          “My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Guidelines to prevent youth baseball injuries need more muscle
          Guidelines to prevent youth baseball injuries need more muscle

          Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

          read more
          JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology
          JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

          FogPharmaCEOMathaiMammenVenrockSANFRANCISCO—SixmonthsintohistenureasCEOofcancerstartupFogPharma,Math

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Emergent cuts jobs, executive role in business shake

          SpencerPlatt/GettyImagesEmergentBioSolutions,themanufacturingcompanythatfellintohotwaterin2021duetoa